Search details
1.
An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma.
CA Cancer J Clin
; 72(5): 454-489, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35708940
2.
Advances in non-clear cell renal cell carcinoma management: From heterogeneous biology to treatment options.
Int J Cancer
; 154(6): 947-961, 2024 Mar 15.
Article
in English
| MEDLINE | ID: mdl-37823185
3.
Special populations in metastatic renal cell carcinoma.
Curr Opin Oncol
; 36(3): 186-194, 2024 May 01.
Article
in English
| MEDLINE | ID: mdl-38573208
4.
Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas.
Oncologist
; 28(5): 433-439, 2023 05 08.
Article
in English
| MEDLINE | ID: mdl-36640141
5.
Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas.
Oncologist
; 27(12): 1041-1047, 2022 12 09.
Article
in English
| MEDLINE | ID: mdl-35979929
6.
Outcomes of patients with intermediate-risk or poor-risk metastatic renal cell carcinoma who received their first cycle of nivolumab and ipilimumab in the hospital because of symptomatic disease: The MD Anderson Cancer Center experience.
Int J Cancer
; 149(2): 387-393, 2021 07 15.
Article
in English
| MEDLINE | ID: mdl-33739450
7.
Patient-reported outcomes: what really matters to patients?
Lancet Oncol
; 23(5): e198, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35489342
8.
Everolimus-induced pneumonitis: A diagnostic challenge.
Breast J
; 26(2): 287-288, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31696579
9.
T-cell large granular lymphocytic leukaemia in the context of rheumatoid arthritis.
Lancet
; 392(10152): 1071, 2018 09 22.
Article
in English
| MEDLINE | ID: mdl-30264706
10.
Management of Brain Metastases in Metastatic Renal Cell Carcinoma.
Hematol Oncol Clin North Am
; 37(5): 1005-1014, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37270383
11.
SETD2 Loss and ATR Inhibition Synergize to Promote cGAS Signaling and Immunotherapy Response in Renal Cell Carcinoma.
Clin Cancer Res
; 29(19): 4002-4015, 2023 10 02.
Article
in English
| MEDLINE | ID: mdl-37527013
12.
Current Systemic Treatments for the Hereditary Cancer Syndromes: Drug Development in Light of Genomic Defects.
Am Soc Clin Oncol Educ Book
; 42: 1-17, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35671435
13.
Serum IGF-1 Scores and Clinical Outcomes in the Phase III IMbrave150 Study of Atezolizumab Plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma.
J Hepatocell Carcinoma
; 9: 1065-1079, 2022.
Article
in English
| MEDLINE | ID: mdl-36254201
14.
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial.
Lancet Gastroenterol Hepatol
; 7(3): 208-218, 2022 03.
Article
in English
| MEDLINE | ID: mdl-35065057
15.
MK-6482 as a potential treatment for von Hippel-Lindau disease-associated clear cell renal cell carcinoma.
Expert Opin Investig Drugs
; 30(5): 495-504, 2021 May.
Article
in English
| MEDLINE | ID: mdl-33945366
16.
Outcomes of changing systemic therapy in patients with relapsed breast cancer and 1 to 3 brain metastases.
NPJ Breast Cancer
; 7(1): 28, 2021 Mar 19.
Article
in English
| MEDLINE | ID: mdl-33742001
17.
Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular Carcinoma.
J Hepatocell Carcinoma
; 8: 1195-1207, 2021.
Article
in English
| MEDLINE | ID: mdl-34595140
18.
Breast cancer and high-grade glioma: link or coincidence?
J BUON
; 20(5): 1378-9, 2015.
Article
in English
| MEDLINE | ID: mdl-26537089
19.
The Immunotherapy Revolution in Kidney Cancer Treatment: Scientific Rationale and First-Generation Results.
Cancer J
; 26(5): 419-431, 2020.
Article
in English
| MEDLINE | ID: mdl-32947310
20.
Phase II Study of Carfilzomib in Patients With Refractory Renal Cell Carcinoma.
Clin Genitourin Cancer
; 17(6): 451-456, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31439537